NCT05778058

Brief Summary

It is aIt is aimed to examine the possible benefits and effects of the use of Transcutaneous Auricular Vagus Nerve Stimulation to be applied in healthy individuals for sportive purposes on recovery and sportive performance level.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 15, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
8 months until next milestone

First Posted

Study publicly available on registry

March 21, 2023

Completed
Last Updated

March 21, 2023

Status Verified

March 1, 2023

Enrollment Period

3 months

First QC Date

September 15, 2021

Last Update Submit

March 8, 2023

Conditions

Keywords

Vagus Nerve StimulationPhysiological ParametersRecoveryCycle Ergometer TestTranscutaneous Auricular

Outcome Measures

Primary Outcomes (6)

  • Evaluation of autonomous parameters

    Systolic / diastolic blood pressure (mmHg) will be measured with the Braun sphygmomanometer.

    In the 4-day protocol, it was measured 12 times in total, before and after vagus therapy with the bicycle ergometer test.

  • Numerical Fatigue Rating Scale

    The fatigue NRS is a patient-administered, single-item, 11-point horizontal scale anchored at 0 and 10, with 0 representing 'no fatigue' and 10 representing 'as bad as you can imagine'. Patients are asked to 'please rate your fatigue (weariness, tiredness) by selecting the number.

    In the 4-day protocol, it was measured 12 times in total, before and after vagus therapy with the bicycle ergometer test.

  • Numerical Pain Rating Scale

    Pain intensity is frequently measured on an 11-point pain intensity numerical rating scale (PI-NRS), where 0=no pain and 10=worst possible pain.

    In the 4-day protocol, it was measured 12 times in total, before and after vagus therapy with the bicycle ergometer test.

  • Bicycle Ergometer Test

    All participants will be asked to perform cycling exercise at maximum performance for 30 minutes under a load of 30 watts. Then, the distance (meters) covered during the exercise will be evaluated for the sportive performance of the participants.

    It was measured 4 times in aggregation in the 4-day protocol.

  • Lactat Scout

    For lactic acid analysis measurement, the middle fingertip of the athlete is disinfected with an alcohol swab and a blood sample is taken by puncturing the finger.The measuring range is 0.5 - 0.25 mmol/L.

    It was measured 4 times in total on the 1st and 2nd days of the 4-day protocol.

  • Polar H10

    RR times transferred to computer with Polar H10 are used in heart rate variability analysis. Heart rate data will be transferred to the Kubios program and heart rate variability parameters will be calculated and data on the autonomic nervous system (RMSSD, PNS index, Stress index, SNS index, pNN50, Power LF, Power HF and LF/HF ratio) will be obtained.

    It was measured 4 times in total on the 1st and 2nd days of the 4-day protocol.

Study Arms (3)

Unilateral Stimulation

EXPERIMENTAL

After evaluating with 7 different parameters on the first, second, third and fourth days of the protocol, the participants in all groups will be asked to do cycling exercise with maximum performance for 30 minutes under the same wattage load. It will be re-evaluated after the cycling exercise application. After the assessment is complete, stimulation will be given with Vagustim non-invasively for 30 minutes. After vagus nerve stimulation, a re-evaluation will be made and the protocol for that day will be terminated. With the Vagustim device, vagus nerve stimulation will be applied in one ear for 20 minutes, with a frequency of 10 Hz, a pulse width of 300 μs in Modulation mode, and a constant current that the participant will feel the current comfortably.

Device: Unilateral StimulationDiagnostic Test: Bicycle Ergometer TestDiagnostic Test: Lactat ScoutDiagnostic Test: Polar H10Device: Vagustim Device

Bilateral Stimulation

EXPERIMENTAL

After evaluating with 7 different parameters on the first, second, third and fourth days of the protocol, the participants in all groups will be asked to do cycling exercise with maximum performance for 30 minutes under the same wattage load. It will be re-evaluated after the cycling exercise application. After the assessment is complete, stimulation will be given with Vagustim non-invasively for 20minutes. After vagus nerve stimulation, a re-evaluation will be made and the protocol for that day will be terminated. With the Vagustim device, vagus nerve stimulation will be applied in bilateral ear for 20 minutes, with a frequency of 10 Hz, a pulse width of 300 μs in Modulation mode, and a constant current that the participant will feel the current comfortably.

Device: Bilateral StimulationDiagnostic Test: Bicycle Ergometer TestDiagnostic Test: Lactat ScoutDiagnostic Test: Polar H10Device: Vagustim Device

Bilateral Sham Stimulation

SHAM COMPARATOR

After evaluating with 7 different parameters on the first, second, third and fourth days of the protocol, the participants in all groups will be asked to do cycling exercise with maximum performance for 30 minutes under the same wattage load. Bisiklet egzersiz uygulaması sonrasında tekrar değerlendirilecektir. It will be re-evaluated after the cycling exercise. After the assessment is complete, sham stimulation with Vagustim for 20 minutes will be given non-invasively. After vagus nerve stimulation, a re-evaluation will be made and the protocol for that day will be terminated.

Device: Bilateral Sham StimulationDiagnostic Test: Bicycle Ergometer TestDiagnostic Test: Lactat ScoutDiagnostic Test: Polar H10Device: Vagustim Device

Interventions

With the Vagustim device, vagus nerve stimulation will be applied in one ear for 20 minutes, with a frequency of 10 Hz, a pulse width of 300 μs in Modulation mode, and a constant current that the participant will feel the current comfortably.

Unilateral Stimulation

With the Vagustim device, vagus nerve stimulation will be applied in one ear for 20 minutes, with a frequency of 10 Hz, a pulse width of 300 μs in Modulation mode, and a constant current that the participant will feel the current comfortably.

Bilateral Stimulation

Participants were shown that the device was working, but no current was given.

Bilateral Sham Stimulation
Bicycle Ergometer TestDIAGNOSTIC_TEST

Participants in this group were asked to perform bicycle exercise with maximum performance under 30 watts for 30 minutes.

Bilateral Sham StimulationBilateral StimulationUnilateral Stimulation
Lactat ScoutDIAGNOSTIC_TEST

For lactic acid analysis measurement, the middle fingertip of the athlete is disinfected with an alcohol swab and a blood sample is taken by puncturing the finger.The measuring range is 0.5 - 0.25 mmol/L.

Bilateral Sham StimulationBilateral StimulationUnilateral Stimulation
Polar H10DIAGNOSTIC_TEST

RR times transferred to computer with Polar H10 are used in heart rate variability analysis. Heart rate data will be transferred to the Kubios program and heart rate variability parameters will be calculated and data on the autonomic nervous system (RMSSD, PNS index, Stress index, SNS index, pNN50, Power LF, Power HF and LF/HF ratio) will be obtained.

Bilateral Sham StimulationBilateral StimulationUnilateral Stimulation

Vagustim Health Technologies Vagus stimulator device is used for this experiment.

Bilateral Sham StimulationBilateral StimulationUnilateral Stimulation

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy individuals between the ages of 18-35,
  • Willingness to participate in the study
  • Having signed the informed consent form

You may not qualify if:

  • Cases do not want to continue the study.
  • Having regular sports habits or starting in the working process,
  • Having a disease related to the respiratory system and starting to use drugs
  • Having a disease related to the cardiac system and starting to use drugs
  • Presence of any chronic disease and using a drug related to it

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sefa Haktan Hatik

Sinop, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • SEFA HAKTAN HATIK, Asst. Prof

    Sinop University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: 90 healthy young individuals were included in the study. Participants were randomly divided into 3 groups as unilateral (n=30, 15 female, 15 male), bilateral (n=30, 15 female, 15 male) and bilateral sham (n=30, 15 female, 15 male) groups. ). The cycling exercise was performed at maximum performance for 30 minutes under the same wattage load. Non-invasive ear stimulation was performed with the Vagustim device according to the participant groups. Pulse, systolic and diastolic blood pressure, distance, pain, fatigue, lactic acid level and autonomic nervous system were evaluated before, after and at the end of cycling exercise. Oneway Anova test and Kruskal Wallis test were used between groups. Dunn's test was used to determine the group that caused the difference. Analysis of variance was used for repeated measurements, Bonferroni test and Friedman test were used for in-group comparisons. Significance was evaluated at the p\<0.05 level.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2021

First Posted

March 21, 2023

Study Start

March 1, 2022

Primary Completion

June 1, 2022

Study Completion

August 1, 2022

Last Updated

March 21, 2023

Record last verified: 2023-03

Locations